ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Geriatric Medicine

Top Geriatric Medicine Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CALVIN VANREKEN MD

Geriatric Medicine

1,217

$106K

48
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 21%

$87
Average prescription price

Avg: $44

LISA ROSENBERG MD

Geriatric Medicine

1,606

$101K

108
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$63
Average prescription price

Avg: $44

STEVEN PHILLIPS M.D.

Geriatric Medicine

3,605

$83.9K

259
224 are 65+

11%
patients receiving schedule two controlled substances

Avg: 12%

8%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 21%

$23
Average prescription price

Avg: $44

MIRIT AVRAM M.D.

Geriatric Medicine

3,938

$130K

325
281 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

16%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 21%

$33
Average prescription price

Avg: $44

SHAWN MCGIVNEY M.D.

Geriatric Medicine

4,537

$172K

131
83 are 65+

8%
patients receiving schedule two controlled substances

Avg: 12%

24%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$38
Average prescription price

Avg: $44

UPINDER SINGH MD

Geriatric Medicine

4,720

$264K

276
253 are 65+

9%
patients receiving schedule two controlled substances

Avg: 12%

9%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$56
Average prescription price

Avg: $44

MEL MAGBOO M.D.

Geriatric Medicine

5,000

$205K

218
203 are 65+

14%
patients receiving schedule two controlled substances

Avg: 12%

13%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$41
Average prescription price

Avg: $44

AJAY NELLUTLA M.D.

Geriatric Medicine

5,126

$232K

244
145 are 65+

30%
patients receiving schedule two controlled substances

Avg: 12%

31%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 21%

$45
Average prescription price

Avg: $44

LEONARDO GAN-LIM M.D.

Geriatric Medicine

5,317

$399K

254
207 are 65+

11%
patients receiving schedule two controlled substances

Avg: 12%

23%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 21%

$75
Average prescription price

Avg: $44

SYED HUSSAIN MD

Geriatric Medicine

5,663

$212K

313
218 are 65+

14%
patients receiving schedule two controlled substances

Avg: 12%

20%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 21%

$38
Average prescription price

Avg: $44

MIKE JEONG

Geriatric Medicine

6,010

$259K

280
265 are 65+

8%
patients receiving schedule two controlled substances

Avg: 12%

14%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 21%

$43
Average prescription price

Avg: $44

JEFFREY GINGOLD M.D.

Geriatric Medicine

6,402

$262K

316
294 are 65+

15%
patients receiving schedule two controlled substances

Avg: 12%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 21%

$41
Average prescription price

Avg: $44

LAURENCE GAY MD

Geriatric Medicine

6,707

$273K

280
241 are 65+

17%
patients receiving schedule two controlled substances

Avg: 12%

13%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 21%

$41
Average prescription price

Avg: $44

ROOPA DANI MD

Geriatric Medicine

11,217

$446K

939
832 are 65+

4%
patients receiving schedule two controlled substances

Avg: 12%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 21%

$40
Average prescription price

Avg: $44

ROLAND JAYSON PUA MD

Geriatric Medicine

13,778

$503K

389
350 are 65+

12%
patients receiving schedule two controlled substances

Avg: 12%

15%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$37
Average prescription price

Avg: $44

BARNALI HIREMATH MD

Geriatric Medicine

17,781

$981K

940
773 are 65+

9%
patients receiving schedule two controlled substances

Avg: 12%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$55
Average prescription price

Avg: $44

SYED RAHMAN M.D.

Geriatric Medicine

20,225

$880K

477
317 are 65+

28%
patients receiving schedule two controlled substances

Avg: 12%

26%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$43
Average prescription price

Avg: $44

DENVER MILLER MD, MPH, CMD

Geriatric Medicine

22,076

$926K

959
860 are 65+

12%
patients receiving schedule two controlled substances

Avg: 12%

16%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$42
Average prescription price

Avg: $44

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank